MedPath

Exelan Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

63

FDA:63

Drug Approvals

GABAPENTIN

Approval Date
May 1, 2025
FDA

Tamsulosin hydrochloride

Approval Date
Feb 1, 2025
FDA

darunavir

Approval Date
Jan 19, 2024
FDA

Nadolol

Approval Date
Jan 1, 2024
FDA

LISINOPRIL

Approval Date
Dec 19, 2023
FDA

OSELTAMIVIR PHOSPHATE

Approval Date
Nov 1, 2023
FDA

Phytonadione

Approval Date
Nov 1, 2023
FDA

OSELTAMIVIR PHOSPHATE

Approval Date
Sep 1, 2023
FDA

SERTRALINE

Approval Date
Sep 1, 2023
FDA

Escitalopram oxalate

Approval Date
Sep 1, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.